Cargando…
Clinical studies involving probiotics: When FDA’s investigational new drug rubric applies—and when it may not
Researchers from a diverse array of scientific disciplines have focused and continue to focus on opportunities and areas for responsible clinical research involving the possible beneficial health effects of “probiotics.” Investigators and researchers should be aware that not all clinical research in...
Autor principal: | Degnan, Fred H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495785/ https://www.ncbi.nlm.nih.gov/pubmed/23060015 http://dx.doi.org/10.4161/gmic.22158 |
Ejemplares similares
-
Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017) -
The effects of lobbying on the FDA’s recall classification
por: Zhou, Yifan
Publicado: (2023) -
Can the COVID-19 interstate travel restrictions help lift the FDA’s blood ban?
por: Dorfman, Doron
Publicado: (2020) -
New science, drug regulation, and emergent public health issues: The work of FDA’s division of applied regulatory science
por: Chiu, Kimberly, et al.
Publicado: (2023) -
COVID-19 emergency responders in FDA’s Center for Drug Evaluation and Research
por: Gormley, Lieutenant Commander Andrea, et al.
Publicado: (2020)